Navigating social and ethical challenges of biobanking for human microbiome research

BMC Medical Ethics

Volumn 18, Issue 1, 2017, Pages 1-10

  Chuong, Kim H ^a   Hwang, David M ^b,c   Tullis, D Elizabeth ^d,e   Waters, Valerie J ^d,f   Yau, Yvonne C W ^b,f   Guttman, David S ^g   O’Doherty, Kieran C ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biobank; Cystic fibrosis; Identifiability; Incidental findings; Microbiome; Research ethics; Return of results

Indexed keywords

BIOBANK; CANADA; CONFIDENTIALITY; CYSTIC FIBROSIS; ETHICS; HUMAN; INCIDENTAL FINDING; INFORMATION DISSEMINATION; INTERPERSONAL COMMUNICATION; LUNG; MEDICAL RESEARCH; MICROBIOLOGY; MICROFLORA; PRIVACY; PUBLIC HEALTH; PUBLIC OPINION; RESEARCH ETHICS;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; CANADA; CONFIDENTIALITY; CYSTIC FIBROSIS; DISCLOSURE; ETHICS, RESEARCH; HUMANS; INCIDENTAL FINDINGS; INFORMATION DISSEMINATION; LUNG; MICROBIOTA; PRIVACY; PUBLIC HEALTH; PUBLIC OPINION;

EID: 85009228753     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/s12910-016-0160-y     Document Type: Article

References (58)

1. Henderson GE, Juengst ET, King NMP, Kuczynski K, Michie M. What research ethics should learn from genomics and society research: Lessons from the ELSI Congress of 2011. J Law Med Ethics. 2012;40(4):1008-24.
2. Hewitt RE. Biobanking: The foundation of personalized medicine. Curr Opin Oncol. 2011;23:112-9.
3. Ratjen F, Dӧring G. Cystic fibrosis. Lancet. 2003;361:681-9.
4. Stephenson AL, Tom M, Berthiaume Y, Singer LG, Aaron SD, Whitmore GA, Stanojevic S. A contemporary survival analysis of individuals with cystic fibrosis: A cohort study. Eur Respir J. 2015;45(3):670-9.
5. Li K, Bihan M, Methé BA. Analyses of the stability and core taxonomic memberships of the human microbiome. PLoS One. 2013;8(5):e63139.
6. Proctor LM. The Human Microbiome Project in 2011 and beyond. Cell Host Microbe. 2011;10(4):287-91.
7. Hoffmann DE, Fortenberry JD, Ravel J. Are changes to the Common Rule necessary to address evolving areas of research? A case study focusing on the Human Microbiome Project. J Law Med Ethics. 2013;41(2):454-69.
8. Lewis CM, Obregón-Tito A, Tito RY, Foster MW, Spicer PG. The Human Microbiome Project: Lessons from human genomics. Trends Microbiol. 2012;20(1):1-4.
9. Flint HJ, Scott KP, Louis P, Duncan SH. The role of gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9(10):577-89.
10. Kinross JM, von Roon AC, Holmes E, Darzi A, Nicholson JK. The human gut microbiome: Implications for future health care. Curr Gastroenterol Rep. 2008;10(4):396-403.
11. Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Annu Rev Pathol Mech Dis. 2012;7:99-122.
12. Albenberg LG, Wu GD. Diet and the intestinal microbiome: Associations, functions, and implications for health and disease. Gastroenterology. 2014;146(6):1564-72.
13. Winglee K, Fodor AA. Intrinsic association between diet and the gut microbiome: Current evidence. Nutr Diet Suppl. 2015;7:69-76.
14. Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: Mechanisms of intestinal immunomodulation and neuromodulation. Ther Adv Gastroenterol. 2013;6(1):39-51.
15. Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: Gastroenterology enters the metagenomics era. Gastroenterology. 2009;136(6):2015-31.
16. Versalovic J. The human microbiome and probiotics: Implications for pediatrics. Ann Nutr Metab. 2013;63 Suppl 2:42-52.
17. Petrof EO, Claud EC, Gloor GB, Allen-Vercoe E. Microbial ecosystems therapeutics: a new paradigm in medicine? Benefic Microbes. 2013;4(1):53-65.
18. Hawkins AK, O’Doherty KC. “Who owns your poop?” Insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Med Genet. 2011;4:72.
19. McGuire AL, Colgrove J, Whitney SN, Diaz CM, Bustillo D, Versalovic J. Ethical, legal, and social considerations in conducting the Human Microbiome Project. Genome Res. 2008;18(12):1861-4.
20. McGuire AL, Achenbaum LS, Whitney SN, Slashinski MJ, Versalovic J, Keitel WA, McCurdy SA. Perspectives on human microbiome research ethics. J Empir Res Hum Res Ethics. 2012;7(3):1-14.
21. Rhodes R, Gligorov N, Schwab AP, editors. The human microbiome: Ethical, legal and social concerns. New York: Oxford University Press; 2013.
22. Slashinski MJ, McCurdy SA, Achenbaum LS, Whitney SM, McGuire AL. “Snake-oil”, “quack medicine”, and “industrially cultured organisms:” Biovalue and the commercialization of human microbiome research. BMC Med Ethics. 2012;13:28.
23. Sonnenburg JL, Fischbach MA. Community health care: Therapeutic opportunities in the human microbiome. Sci Transl Med. 2011;3(78):78ps12.
24. Hou JK, Lee D, Lewis J. Diet and inflammatory bowel disease: Review of patient-targeted recommendations. Clin Gastroenterol Hepatol. 2014;12(10):1592-600.
25. Allen-Vercoe E, Reid G, Viner N, Gloor GB, Hota S, Kim P, et al. A Canadian Working Group report on fecal microbial therapy: Microbial ecosystem therapeutics. Can J Gastroenterol. 2012;26(7):457-62.
26. Landy J, Al-Hassi HO, McLaughlin SD, Walker AW, Ciclitira PJ, Nicholls RJ, et al. Faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther. 2011;34(4):409-15.
27. Khoruts A, Sadowsky MJ. Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol. 2011;4(1):4-7.
28. Chuong KH, O’Doherty KC, Secko DM. Media discourse on the social acceptability of fecal transplants. Qual Health Res. 2015;25(10):1359-71.
29. Health Canada. http://www.hc-sc.gc.ca/dhp-mps/consultation/biolog/fecal_microbiota-bacterio_fecale-eng.php (2015). Accessed 22 Sept 2016.
30. O’Doherty KC, Virani A, Wilcox ES. The human microbiome and public health: Social and ethical considerations. AJPH Perspect Soc Sci. 2016;106(3):414-20.
31. Clarke SF, Murphy EF, O’Sullivan O, Lucey AJ, Humphreys M, Hogan A, et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63(12):1913-20.
32. Schwarz S, Morelli G, Kusecek B, Manica A, Balloux F, Owen RJ, et al. Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog. 2008;4(10):e1000180.
33. Kort R, Caspers M, van de Graaf A, van Egmond W, Keijser B, Roeselers G. Shaping the oral microbiota through intimate kissing. Microbiome. 2014;2:41.
34. Abeles SR, Jones MB, Santiago-Rodriguez TM, Ly M, Klitgord N, Yooseph S, et al. Microbial diversity in individuals and their household contacts following typical antibiotic courses. Microbiome. 2016;4(1):39.
35. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007;449(7164):811-8.
36. Rhodes R. Introduction: Looking back and looking forward. In: Rhodes R, Gligorov N, Schwab AP, editors. The human microbiome: Ethical, legal and social concerns. New York: Oxford University Press; 2013. p. 1-15.
37. O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7(7):688-93.
38. Gligorov N, Azzouni J, Lackey DP, Zweig A. Personal identity: Our microbes, ourselves. In: Rhodes R, Gligorov N, Schwab AP, editors. The human microbiome: Ethical, legal and social concerns. New York: Oxford University Press; 2013. p. 55-70.
39. Nerlich B, Hellsten I. Beyond the human genome: Microbes, metaphors and what it means to be human in an interconnected post-genomic world. New Genet Soc. 2007;28(1):19-36.
40. U.S. National Institutes of Health: Office of Strategic Coordination - The Common Fund. https://commonfund.nih.gov/hmp/datareleaseguidelines (2013). Accessed 19 May 2016.
41. Wolf SM, Crock BN, Van Ness B, Lawrenz F, Kahn JP, Beskow L, et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med. 2012;14(4):361-84.
42. Petersen GM, Van Ness B. Returning a research participant’s genomic results to relatives: Perspectives from managers of two distinct research biobanks. J Law Med Ethics. 2015;43(3):523-8.
43. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174-80.
44. Mason MR, Nagaraja HN, Camerlengo T, Joshi V, Kumar PS. Deep sequencing identifies ethnicity-specific bacterial signatures in the oral microbiome. PLoS One. 2013;8:e77287.
45. Jeffery IB, Claesson MJ, O’Toole PW, Shanahan F. Categorization of the gut microbiota: Enterotypes or gradients? Nat Rev Microbiol. 2012;10(9):591-2.
46. Fierer N, Lauber CL, Zhou N, McDonald D, Costello EK, Knight R. Forensic identification using skin bacterial communities. Proc Natl Acad Sci. 2010;107(14):6477-81.
47. Zakutar JP, Rogers MAM, Ruffin 4th MT, Schloss PD. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res. 2014;7(11):1112-21.
48. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N, Cox LM, Amir A, Gonzalez A, et al. Partial restoration of the microbiota of Cesarean-born infants via vaginal microbial transfer. Nat Med. 2015;22(3):250-3.
49. Coburn B, Wang PW, Caballero JD, Clark ST, Brahma V, Donaldson S, et al. Lung microbiota across age and disease stage in cystic fibrosis. Sci Rep. 2015;5:10241.
50. Hampton TH, Green DM, Cutting GR, Morrison HG, Sogin ML, Gifford AH, et al. The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome. 2014;2:14.
51. Alexander BD, Petzold EW, Reller LB, Palmer SM, Davis RD, Woods CW, LiPuma JJ. Survival after lung transplantation of Cystic Fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant. 2008;8(5):1025-30.
52. De Soyza A, Meachery G, Hester KLM, Nicholson A, Parry G, Tocewicz K, et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: A single-center experience. J Heart Lung Transplant. 2010;29(12):1395-404.
53. Bredenoord AL, Kroes HY, Cuppen E, Parker M, van Delden JJM. Disclosure of individual genetic data to research participants: The debate reconsidered. Trends Genet. 2011;27(2):41-7.
54. Burke W, Evans BJ, Jarvik GP. Return of results: Ethical and legal distinctions between research and clinical care. Am J Med Genet C Semin Med Genet. 2014;166:105-11.
55. Rahimzadeh V, Avard D, Sénécal K, Knoppers BM, Sinnett D. To disclose, or not to disclose? Context matters. Eur J Hum Genet. 2015;23(3):279-84.
56. Schwab AP, Brenner B, Goldfarb J, Hirschhorn R, Philpott S. Biobanks and the human microbiome. In: Rhodes R, Gligorov N, Schwab AP, editors. The human microbiome: Ethical, legal and social concerns. New York: Oxford University Press; 2013. p. 182-207.
57. Beskow LM, O’Rourke PP. Return of genetic research results to participants and families: IRB perspectives and roles. J Law Med Ethics. 2015;43(3):502-13.
58. Fernandez CV, O’Rourke PP, Beskow LM. Canadian research ethics board leadership attitudes to the return of genetic research results to individuals and their families. J Law Med Ethics. 2015;43(3):514-22.